MANATEE COUNTY -- State College of Florida, Manatee-Sarasota, The Bradenton Area Economic Development Corporation, the Economic Development Corporation of Sarasota County and CareerSource Suncoast have partnered to help local companies increase exports by helping pay for employee training or customized consulting services.
The money for the program will come through a Trade and Logistics Challenge Grant.
For-profit companies that have been in business for at least one year and are involved in any export-related activity are eligible and invited to attend a workshop 7:30-9 a.m. Feb. 27, at SCF Lakewood Ranch, 7131 Professional Pkwy. E. Applications will be accepted following the workshop.
Funded by Workforce Florida, the grant is designed to aid companies that plan to launch or expand the exports from Florida. Workforce Florida's mission is to access new global markets and bolster Florida's role as an International Trade Hub.
Training covered under the grant includes: AST&L Certification in Transportation & Logistics, ISO 9001 & 14001 - Lean Supply Chain, Incoterms 2010 and International Payments, Protecting Intellectual Property, A Basic Guide to Exporting, Export Compliance - ITAR and EAR, Customs and International Logistics, Regulatory and Product Certifications, Identification of Export Opportunities, Market Entry Strategies - Direct & Indirect, International Trade - Tariffs & Landed Cost, Supply Chain Management, Customized Export Training Programs and Understanding Trade Agreements. Pricing will vary by program, but the grant will cover about 75 percent of training costs.
Manatee Memorial doctor implants new defibrillator
MANATEE COUNTY -- Manatee Memorial Hospital is the first local hospital to implant the Boston Scientific S-ICD System, the only commercially available subcutaneous implantable defibrillator for the treatment of patients at risk for sudden cardiac arrest.
The implantation was performed by Dr. Joseph Pace in Manatee Memorial's Heart and Vascular Center's Hybrid Catheterization Lab this week.
Recent estimates show that approximately 850,000 people in the United States are at risk of sudden cardiac arrest, but remain unprotected.
The S-ICD System is designed to provide the same protection from cardiac arrest as traditional transvenous implantable cardioverter defibrillators. However, the S-ICD System sits just below the skin without the need for thin, insulated wires - known as leads - to be placed into the heart itself. This leaves the heart and blood vessels untouched, providing a new option for both physicians and patients.
The S-ICD System is intended to provide defibrillation therapy for the
treatment of life-threatening ventricular tachyarrhythmias in patients who do not have symptomatic bradycardia, incessant ventricular tachycardia, or spontaneous, frequently recurring ventricular tachycardia that is reliably terminated with anti-tachycardia pacing.
The U.S. Food and Drug Administration granted regulatory approval for the S-ICD System in September of 2012. More than 2,000 devices have been implanted in patients around the world.
Herald staff report